SC
PFE icon

Stolper & Co’s Pfizer PFE Stock Holding History

Stolper & Co’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.53M Buy
63,611
+30,553
+92% +$799K 0.4% 59
2026
Q1 		$531K Sell
33,058
-28,240
-46% -$752K 0.15% 79
2025
Q4 		$1.53M Buy
61,298
+2,651
+5% +$66.9K 0.45% 57
2025
Q3 		$1.49M Buy
58,647
+3,170
+6% +$78.2K 0.45% 57
2025
Q2 		$1.34M Buy
55,477
+3,888
+8% +$90.7K 0.44% 58
2025
Q1 		$1.31M Buy
51,589
+1,604
+3% +$42K 0.43% 58
2024
Q4 		$1.33M Buy
49,985
+113
+0.2% +$3.06K 0.44% 57
2024
Q3 		$1.44M Sell
49,872
-318
-0.6% -$9.28K 0.47% 58
2024
Q2 		$1.4M Buy
50,190
+1,841
+4% +$50.7K 0.49% 57
2024
Q1 		$1.34M Buy
48,349
+4,036
+9% +$112K 0.48% 57
2023
Q4 		$1.28M Sell
44,313
-1,807
-4% -$54.6K 0.51% 55
2023
Q3 		$1.53M Buy
46,120
+1,167
+3% +$41.3K 0.66% 50
2023
Q2 		$1.65M Buy
44,953
+234
+0.5% +$9.11K 0.69% 47
2023
Q1 		$1.82M Buy
44,719
+620
+1% +$26.8K 0.78% 39
2022
Q4 		$2.26M Sell
44,099
-7,237
-14% -$347K 0.99% 31
2022
Q3 		$2.25M Buy
51,336
+2,475
+5% +$120K 1.11% 32
2022
Q2 		$2.56M Buy
48,861
+1,668
+4% +$85K 1.2% 30
2022
Q1 		$2.44M Buy
47,193
+1,562
+3% +$81K 1.04% 31
2021
Q4 		$2.69M Buy
45,631
+430
+1% +$21.3K 1.2% 27
2021
Q3 		$1.94M Buy
45,201
+959
+2% +$42.5K 0.93% 33
2021
Q2 		$1.73M Buy
44,242
+762
+2% +$29.6K 0.82% 37
2021
Q1 		$1.57M Buy
43,480
+605
+1% +$21.5K 0.81% 40
2020
Q4 		$1.58M Sell
42,875
-1,296
-3% -$47.5K 0.89% 38
2020
Q3 		$1.54M Sell
44,171
-4,020
-8% -$141K 0.99% 33
2020
Q2 		$1.5M Sell
48,191
-3,220
-6% -$109K 0.98% 36
2020
Q1 		$1.59M Buy
+51,411
New +$1.75M 1.14% 34

Other funds holding PFE

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
ORIO
Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
KC
Kepler Cheuvreux Nyon $1.75B AUM 37.37% 1-Year Est. Return
WAM
Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

Stolper & Co's PFE Position: Q2 2026 in Review

Stolper & Co increased its Pfizer (PFE) stake by 92% in Q2 2026, buying an estimated $799K and bringing the position to 63,611 shares worth $1.53M. The position accounts for 0.4% of the portfolio, ranked #59.

Stolper & Co first reported a position in PFE in Q1 2020 and has held it in 26 quarters since. The position peaked at $2.69M in Q4 2021. 557 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Stolper & Co held 63,611 shares of Pfizer worth $1.53M as of Q2 2026.
  • Stolper & Co bought 30,553 Pfizer shares in Q2 2026, an estimated $799K.
  • Pfizer made up 0.4% of Stolper & Co's portfolio in Q2 2026, its #59 holding.
  • Stolper & Co first reported a position in Pfizer in Q1 2020 and has held it in 26 quarters since.
  • Stolper & Co's Pfizer position peaked at $2.69M in Q4 2021.
  • 557 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Stolper & Co's 13F filing for Q2 2026, filed 14 Jul 2026.